Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon M Laws

Showing results (161-170 of 190) with videos related to

Pageof 19
Sort By:
Neurology|November 13, 2020
Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older IndividualsLaura M van der Kall, Thanh Truong, Samantha C Burnham, et al.
Human Molecular Genetics|July 19, 2015
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosisBen J Gu, Judith Field, Sébastien Dutertre, et al.
Human Molecular Genetics|July 11, 2006
A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's diseaseMatthias Riemenschneider, Lidija Konta, Patricia Friedrich, et al.
Journal of Alzheimer'S Disease : JAD|January 30, 2018
Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-βW M A D Binosha Fernando, Stephanie R Rainey-Smith, Samantha L Gardener, et al.
Alzheimer'S Research & Therapy|September 23, 2020
Age and APOE genotype affect the relationship between objectively measured physical activity and power in the alpha band, a marker of brain diseaseJaisalmer de Frutos-Lucas, Pablo Cuesta, Federico Ramírez-Toraño, et al.
The Journal of Prevention of Alzheimer'S Disease|January 1, 2026
Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scansAzadeh Feizpour, Vincent Doré, Pierrick Bourgeat, et al.
Journal of Alzheimer'S Disease : JAD|November 25, 2017
Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay PlatformsJames D Doecke, Alan Rembach, Victor L Villemagne, et al.
Alzheimer'S Research & Therapy|November 20, 2015
Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodologyAlan Rembach, Lisbeth A Evered, Qiao-Xin Li, et al.
Frontiers in Aging Neuroscience|March 6, 2015
Bone mineral density, adiposity, and cognitive functionsHamid R Sohrabi, Kristyn A Bates, Michael Weinborn, et al.
Neuroimage|July 22, 2025
A large-scale multi-centre study characterising atrophy heterogeneity in Alzheimer's diseaseVikram Venkatraghavan, Damiano Archetti, Pierrick Bourgeat, et al.
Pageof 19

Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Neurology|November 13, 2020
Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older IndividualsLaura M van der Kall, Thanh Truong, Samantha C Burnham, et al.
Human Molecular Genetics|July 19, 2015
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosisBen J Gu, Judith Field, Sébastien Dutertre, et al.
Human Molecular Genetics|July 11, 2006
A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's diseaseMatthias Riemenschneider, Lidija Konta, Patricia Friedrich, et al.
Journal of Alzheimer'S Disease : JAD|January 30, 2018
Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-βW M A D Binosha Fernando, Stephanie R Rainey-Smith, Samantha L Gardener, et al.
Alzheimer'S Research & Therapy|September 23, 2020
Age and APOE genotype affect the relationship between objectively measured physical activity and power in the alpha band, a marker of brain diseaseJaisalmer de Frutos-Lucas, Pablo Cuesta, Federico Ramírez-Toraño, et al.
The Journal of Prevention of Alzheimer'S Disease|January 1, 2026
Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scansAzadeh Feizpour, Vincent Doré, Pierrick Bourgeat, et al.
Journal of Alzheimer'S Disease : JAD|November 25, 2017
Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay PlatformsJames D Doecke, Alan Rembach, Victor L Villemagne, et al.
Alzheimer'S Research & Therapy|November 20, 2015
Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodologyAlan Rembach, Lisbeth A Evered, Qiao-Xin Li, et al.
Frontiers in Aging Neuroscience|March 6, 2015
Bone mineral density, adiposity, and cognitive functionsHamid R Sohrabi, Kristyn A Bates, Michael Weinborn, et al.
Neuroimage|July 22, 2025
A large-scale multi-centre study characterising atrophy heterogeneity in Alzheimer's diseaseVikram Venkatraghavan, Damiano Archetti, Pierrick Bourgeat, et al.
Pageof 19